AZD1981 Bioavailability study of Intravenous (IV) and oral formulations

Study identifier:D9831C00003

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open, Single-dose, Phase I, 4-period partly Crossover Study in Healthy Men or Women to Assess Relative Bioavailability of Oral Administration of AZD1981 via Tablets Compared with Suspension and Basic Systemic Pharmacokinetic Parameters after Intravenous Administration

Medical condition

Healthy, postmenopausal

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD1981

Sex

All

Actual Enrollment

14

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 01 Jun 2009
Primary Completion Date: -
Study Completion Date: 01 Jul 2009

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria